{
  "cik": 1974640,
  "cik_padded": "0001974640",
  "entityName": "Apogee Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001974640-26-000002",
      "filed": "2026-03-02",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5147000.0,
        "cash": 131549000.0,
        "eps_diluted": -4.22,
        "free_cash_flow": -232597000.0,
        "net_income": -255843000.0,
        "operating_cash_flow": -227450000.0,
        "operating_income": -285595000.0,
        "total_assets": 937134000.0,
        "total_liabilities": 33251000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.3025785220731069,
        "roa_period_end": -0.2730057814570808
      }
    },
    {
      "accn": "0001974640-26-000002",
      "filed": "2026-03-02",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1152000.0,
        "cash": 141789000.0,
        "eps_diluted": -3.3,
        "free_cash_flow": -172326000.0,
        "net_income": -182146000.0,
        "operating_cash_flow": -171174000.0,
        "operating_income": -216870000.0,
        "total_assets": 753951000.0,
        "total_liabilities": 37157000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.31530741633523895,
        "roa_period_end": -0.2415886443548719
      }
    },
    {
      "accn": "0001974640-26-000002",
      "filed": "2026-03-02",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 167000.0,
        "cash": 118316000.0,
        "eps_diluted": -3.36,
        "free_cash_flow": -74928000.0,
        "net_income": -83985000.0,
        "operating_cash_flow": -74761000.0,
        "operating_income": -93003000.0,
        "total_assets": 401404000.0,
        "total_liabilities": 21491000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.303491315526534,
        "roa_period_end": -0.20922810933622984
      }
    },
    {
      "accn": "0001558370-24-002406",
      "filed": "2024-03-05",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 151890000.0,
        "eps_diluted": -16.16,
        "net_income": -39785000.0,
        "operating_cash_flow": -16427000.0,
        "operating_income": -30727000.0,
        "total_assets": 152055000.0,
        "total_liabilities": 9980000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_period_end": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.2616487455197133
      }
    }
  ],
  "latest_filing": {
    "accn": "0001974640-26-000002",
    "filed": "2026-03-02",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001974640.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001974640.json"
  },
  "ticker": "APGE"
}